Scientific Opinion on the substantiation of health claims related to arabinoxylan produced from wheat endosperm and reduction of post-prandial glycaemic responses (ID 830) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 9, Issue 6, 2011, Pages

[No Author Info available]

Author keywords

Arabinoxylan; fibre; health claims; post prandial glycaemic responses; post prandial insulinaemic responses

Indexed keywords

EID: 85078378769     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2205     Document Type: Note

References (4)

1. Lu ZX, Walker KZ, Muir JG, Mascara T and O'Dea K, 2000. Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects. American Journal of Clinical Nutrition, 71, 1123–1128.
2. Lu ZX, Walker KZ, Muir JG and O'Dea K, 2004. Arabinoxylan fibre improves metabolic control in people with Type II diabetes. European Journal of Clinical Nutrition, 58, 621–628.
3. Möhlig M, Koebnick C, Weickert MO, Lueder W, Otto B, Steiniger J, Twilfert M, Meuser F, Pfeiffer AF and Zunft HJ, 2005. Arabinoxylan-enriched meal increases serum ghrelin levels in healthy humans. Hormone and Metabolic Research, 37, 303–308.
4. Venn BJ and Green TJ, 2007. Glycemic index and glycemic load: measurement issues and their effect on diet-disease relationships. European Journal of Clinical Nutrition, 61 Suppl 1, S122–131.